Touchstone International Medical Science Co (SHSE:688013) ROIC %: 5.84% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688013 Touchstone International Medical Science Co Ltd SHSE:688013
83 GF Score
Price ¥22.61
GF Value ¥28.55
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Touchstone International Medical Science Co ROIC %?

Touchstone International Medical Science Co SHSE:688013 -1.35% 83 ROIC % is 5.84% as of Mar. 2026. GuruFocus rates SHSE:688013 with a GF Score™ of 83/100 and a GF Value™ of ¥28.55 (Modestly Undervalued). The stock has 2 warning signs investors should review.

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Touchstone International Medical Science Co's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2026 was 5.84%.

As of today (2026-07-28), Touchstone International Medical Science Co's WACC % is 13.19%. Touchstone International Medical Science Co's ROIC % is 20.87% (calculated using TTM income statement data). Touchstone International Medical Science Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Touchstone International Medical Science Co  (SHSE:688013) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Touchstone International Medical Science Co's WACC % is 13.19%. Touchstone International Medical Science Co's ROIC % is 20.87% (calculated using TTM income statement data). Touchstone International Medical Science Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Touchstone International Medical Science Co ROIC % Related Terms


Touchstone International Medical Science Co ROIC % Historical Data

* Premium members only.

The historical data trend for Touchstone International Medical Science Co's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Touchstone International Medical Science Co ROIC % Chart

Touchstone International Medical Science Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROIC %
Get a 7-Day Free Trial Premium Member Only 29.81 26.90 20.01 25.02 25.37

Touchstone International Medical Science Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.15 40.57 31.17 13.06 5.84

SHSE:688013 vs ISRG, BDX, MDLN: ROIC % Comparison

For the Medical Instruments & Supplies subindustry, Touchstone International Medical Science Co's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Touchstone International Medical Science Co ROIC % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Touchstone International Medical Science Co's ROIC % distribution charts can be found below:

* The bar in red indicates where Touchstone International Medical Science Co's ROIC % falls into.


SHSE:688013
83GF Score
Touchstone International Medical Science Co Ltd SHSE:688013
ROIC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Touchstone International Medical Science Co ROIC % Calculation

Touchstone International Medical Science Co's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2025 is calculated as:

ROIC % (A: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2024 ) + Invested Capital (A: Dec. 2025 ))/ count )
=75.627 * ( 1 - 10.49% )/( (196.785 + 336.919)/ 2 )
=67.6937277/266.852
=25.37 %

where

Invested Capital(A: Dec. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=637.24 - 46.107 - ( 395.124 - max(0, 51.313 - 445.661+395.124))
=196.785

Invested Capital(A: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=672.928 - 46.722 - ( 294.005 - max(0, 87.634 - 376.921+294.005))
=336.919

Touchstone International Medical Science Co's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2026 is calculated as:

ROIC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=21.46 * ( 1 - 0% )/( (336.919 + 397.839)/ 2 )
=21.46/367.379
=5.84 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=672.928 - 46.722 - ( 294.005 - max(0, 87.634 - 376.921+294.005))
=336.919

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=694.384 - 32.832 - ( 285.734 - max(0, 103.876 - 367.589+285.734))
=397.839

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROIC % →
What does a ROIC % of 5.84% mean?
Touchstone International Medical Science Co (SHSE:688013) has a ROIC % of 5.84% as of Mar. 2026. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Touchstone International Medical Science Co and its competitors.
Is Touchstone International Medical Science Co's ROIC % too high?
Touchstone International Medical Science Co's current ROIC % is 5.84%. The Medical Devices & Instruments industry median ROIC % is 1.28. Touchstone International Medical Science Co's value of 5.84% is 356.3% above this industry median. Overall, Touchstone International Medical Science Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Touchstone International Medical Science Co's ROIC % compare to ISRG and BDX?
Touchstone International Medical Science Co's ROIC % of 5.84% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROIC % is 1.28. Touchstone International Medical Science Co's value of 5.84% is 356.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROIC % for a Medical Devices & Instruments company?
The median ROIC % among Medical Devices & Instruments companies is 1.28, based on 846 companies in the industry. Companies in the top quartile (top 25%) have a ROIC % significantly above this median, while those in the bottom quartile fall well below. However, ROIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Touchstone International Medical Science Co's current ROIC % of 5.84% is 356.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROIC % mean?
A high ROIC % can signal that a stock is expensive relative to its fundamentals. Return on invested capital is the ratio of current-period net income to average two-period invested capital. View historical data on Touchstone International Medical Science Co and its competitors. For the Medical Devices & Instruments industry, the median ROIC % is 1.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Touchstone International Medical Science Co's current ROIC % is 5.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Touchstone International Medical Science Co stock overvalued right now?
Based on GuruFocus' analysis, Touchstone International Medical Science Co (SHSE:688013) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥28.55, compared to a current price of ¥22.61 — trading 20.8% below its estimated fair value. The current ROIC % is 5.84% and 356.3% above the Medical Devices & Instruments industry median of 1.28. Touchstone International Medical Science Co's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROIC % calculated?
ROIC % is calculated from a company's financial statements. For Touchstone International Medical Science Co (SHSE:688013), the current ROIC % is 5.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Touchstone International Medical Science Co (SHSE:688013) Overvalued in 2026?

Based on GuruFocus' analysis, Touchstone International Medical Science Co stock appears to be undervalued. The current stock price of ¥22.61 is trading 20.8% below its estimated GF Value™ of ¥28.55. GuruFocus considers Touchstone International Medical Science Co to be Modestly Undervalued.

Key valuation signals for SHSE:688013:

  • ROIC %: 5.84%
  • GF Value™: ¥28.55 vs. price of ¥22.61 (20.8% below fair value)
  • GF Score™: 83/100 with 2 warning signs
  • Industry Position: 356.3% above the Medical Devices & Instruments median

No single metric tells the full story. See the SHSE:688013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Touchstone International Medical Science Co Business Description

Address 278 Dongping Street, Suzhou Industrial Park, Suzhou, CHN, 215123
Touchstone International Medical Science Co Ltd is specialized in the development of surgical staplers that enhance clinical performance, minimise risk and improve patient outcomes. The company's products include Auto Purse String Clamp for Single Use (APS); Intraluminal Stapler for Single Use (CSC&ECSC); Endoscopic Linear Cutter and Single Use Loading Unit (ELC&ELCC); Intraluminal Stapler for Single Use (KOL); Linear Cutter and Reloads (LC&LCC); Linear Stapler and Reloads (LS&LSC); PPH Stapler and Purse Sets for Single Use (PPH); Tissue - Selecting Therapy Stapler (TST33); Tissue - Selecting Therapy Stapler (TST36); and Tissue - Selecting Therapy Stapler (Proctology Examination Kit).
83GF Score

Get the complete analysis for SHSE:688013

ROIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥22.61
Price
¥28.55
GF Value